Sp246

PANEL DISCUSSION

Date
May 18, 2024

Presenters


Tracks

Related Products

Thumbnail for CMS COVERAGE DECISION: IMPLICATIONS FOR COST-EFFECITVENESS OF BLOOD-BASED COLORECTAL CANCER SCREENING
CMS COVERAGE DECISION: IMPLICATIONS FOR COST-EFFECITVENESS OF BLOOD-BASED COLORECTAL CANCER SCREENING
A blood-based colorectal cancer (CRC) screening test may increase screening participation. However, blood-based screening tests may be less effective than current guideline-endorsed options…
Thumbnail for CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…